β-blockade, atrial natriuretic peptide and exercise

International Journal of Clinical Pharmacology and Therapeutics

Volumn 34, Issue 1, 1996, Pages 12-16

  Kantola, I ^a,d   Tarssanen, L ^b   Scheinin, M ^a   Ruskoaho, H ^c   Viinamaki, O ^a   Kaila, T ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b MIKKELI CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

blockade; Atrial natriuretic peptide; Exercise; Vasopressin

Indexed keywords

ADRENALIN; ATENOLOL; ATRIAL NATRIURETIC FACTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; NORADRENALIN; PINDOLOL; PROPRANOLOL; VASOPRESSIN;

ADRENALIN BLOOD LEVEL; ADULT; ANIMAL CELL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BICYCLE; BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EXERCISE; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; LUNG; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RABBIT; RANDOMIZED CONTROLLED TRIAL; RAT; RECEPTOR OCCUPANCY; RETICULOCYTE; SYMPATHETIC TONE; TACHYCARDIA; TREATMENT OUTCOME; VASOPRESSIN BLOOD LEVEL;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ATENOLOL; ATRIAL NATRIURETIC FACTOR; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EPINEPHRINE; EXERCISE TEST; HUMANS; MALE; NOREPINEPHRINE; PINDOLOL; PROPRANOLOL; VASOPRESSINS;

EID: 0030063999     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Bollerslev J, Svanegard J, Blaabjerg C, Pindhorg T 1987 Atrial natriuretic peptide in relation to physical exercise. Scand J Clin Lab Invest 47: 681-688
2. Bouissou P, Galen F-X. Richalet JP, Lartigue M, Devaux F, Dubray C, Atlan G 1989 Effects of propranolol and pindolol on plasma ANP levels in humans at rest and during exercise 257: R259-R264
3. Crozier IG, Nicholls MC, Ikram H, Espiner EA, Yandle TG, Jans S 1986 Atrial natriuretic peptide in humans. Production and clearance by various tissues. Hypertension 8 (Suppl 2): 11-15
4. Cruickshank JM, Prichard BNC 1988 Pharmacodynamics. In: Betablockers in Clinical Practice. Churchill Livingstone, Edinburgh, pp 9-175
5. Donckier JE, DeCoster PM, Buysschaert M, Levezque P, Cauwe FM, Brichant CM, Berbinschi AC, Ketelslegers JM 1988 Effect of exercise on plasma natriuretic factor and cardiac function in men and women. Eur J Clin Invest 18: 415-419
6. Donckier JE, DeCoster PM, Buysschaert M, VanHoof M, Cauwe FM, Robert A, Berbinschi AC, Ketelslegers JM 1989 Effect of beta-adrenergic blockade on plasma atrial natriuretic factor and cardiac volumes during exercise in normal men. Am J Cardiol 63: 1000-1002
7. Freund BJ, Wade CE, Claybaugh JR 1988 Effects of exercise on atrial natriuretic factor. Sports Med 6: 364-376
8. 2-receptor occupancy in plasma assesses the antagonist activity of metoprolol, pindolol and propranolol in the elderly. Cardiovasc Drugs Ther 7: 839-849
9. Lilja M, Ikäheimo M, Juustila H, Pirttiaho H, Pakarinen A, Leppäluoto J, Jounela AJ, Ruskoaho H 1989 Abrupt change from a β-adrenoceptor blocking drug to enalapril in hypertension. J Int Med 226: 143-148
10. Nakaoka H, Kitahara Y, Amanso M, Imataka K, Fujii J, Ishibashi M, Yamaji T 1987 Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension. Hypertension 10: 221-225
11. Ruskoaho H 1992 Atrial natriuretic peptide synthesis, release, and metabolism. Pharm Rev 44: 479-602
12. Scheinen M, Koulu M, Laurikainen E, Allonen H 1987 Hypokalemia and other nonbronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose response study in healthy volunteers. Br J Clin Pharmacol 24: 645-653
13. Thamsborg G, Storm T, Keller N, Sykulski R, Larsen J 1987a Changes in plasma atrial natriuretic peptide during exercise in healthy volunteers. Acta Med Scand 221: 441-444
14. 1-adrenoceptor blockade on plasma levels of atrial natriuretic peptide during exercise in normal man. Clin Phys 7: 813-818
15. Tsai R-C, Yamaji T, Ishibashi M, Takaku F, Hsu S-Y, Lai C-Y, Hung J-S, Wu D, Lee Y-S 1988 Effect of beta-adrenergic blockade on plasma levels of atrial natriuretic peptide during exercise in humans. J Cardiovasc Pharmacol 11: 614-618
16. Viinamäki O, Erkkola R, Kanto J 1986 Plasma vasopressin concentrations and serum vasopressinase activity in pregnant and nonpregnant women. Biol Res Pregn 1: 17-19
17. Wellstein A, Palm D, Belz GG, Pitschner HF 1985 Receptor binding characteristics and pharmakokinetic properties as a tool for the prediction on clinical effects of β-blockers. Arzneimittelforschung Drug Res 35: 2-6
18. Wellstein A, Palm D, Belz G-G, Butzer R, Polsak R, Pett B 1987 Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy. Eur Heart J 8 (Suppl M): 3-8
19. Wing LM, Chalmers JP, West MJ, Russell AE, Morris MJ, Cain MD, Bune AJC, Southgate DO 1988 Enalapril and atenolol in essential hypertension, attenuation of hypotensive effects in combination. Clin Exp H 10: 119-133